Suppr超能文献

I 类软件医疗器械(SaMD)对公共健康的影响。

Impact of Class I Software as Medical Devices (SaMDs) on Public Health.

机构信息

Faculty of Medicine and Health Technology, Tampere University, Finland.

出版信息

Stud Health Technol Inform. 2022 Jun 29;295:33-36. doi: 10.3233/SHTI220652.

Abstract

There exist numerous low-risk class I SaMDs with CE marking under European Medical Device Directives (MDD). However, if the manufacturers will make any significant change to these class I SaMDs, the manufacturers shall comply with Medical Device Regulation (MDR) 2017/745 classifications. Class I SaMDs are self-declared without the need for notified body involvement. It is unclear how these devices are monitored if they will undergo any significant changes. Significant change may shift existing low-risk class I SaMDs to higher risk classification. In another hand, it is not clear if all class I SaMDs that are certified under MDD are registered with relevant EU Competent Authorities. Class I SaMDs may have an impact on public health if they are not known and monitored by European competent authorities.

摘要

有许多带有 CE 标志的低风险 I 类 SaMD 根据欧洲医疗器械指令 (MDD)。然而,如果制造商对这些 I 类 SaMD 进行任何重大更改,制造商应遵守医疗器械法规 (MDR) 2017/745 分类。I 类 SaMD 是自行声明的,无需通知机构参与。如果这些设备进行任何重大更改,尚不清楚如何对其进行监测。重大变更可能会将现有的低风险 I 类 SaMD 转移到更高的风险分类。另一方面,目前尚不清楚所有根据 MDD 认证的 I 类 SaMD 是否都在相关的欧盟主管当局进行了注册。如果欧洲主管当局不知道和监测 I 类 SaMD,它们可能会对公共健康产生影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验